Evidence map›Paper›PMID 39861131›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Lucidin from

Akram Ahmed Aloqbi, Hadil Alahdal, Amany I Alqosaibi, Mashael M Alnamshan, Ibtesam S Al-Dhuayan, Ahood A Al-Eidan, Hind A S Alzahrani, Nouf K ALaqeel, Fatmah Hazza Alsharif, Abeer Al Tuwaijri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Akram Ahmed AloqbiDepartment of Biological Science, Faculty of Science, University of Jeddah, Jeddah 21589, Saudi Arabia.ORCID 0000-0001-9554-944X
Hadil AlahdalDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-3075-5514
Amany I AlqosaibiDepartment of Biology, College of Science, Imam Abdulrahman bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.ORCID 0000-0001-8348-9451
Mashael M AlnamshanDepartment of Biology, College of Science, Imam Abdulrahman bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.ORCID 0000-0002-9277-3996
Ibtesam S Al-DhuayanDepartment of Biology, College of Science, Imam Abdulrahman bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.ORCID 0000-0001-6910-0534
Ahood A Al-EidanDepartment of Biology, College of Science, Imam Abdulrahman bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.ORCID 0000-0001-9051-9639
Hind A S AlzahraniDepartment of Biology, College of Science, Imam Abdulrahman bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Nouf K ALaqeelDepartment of Biology, College of Science, Imam Abdulrahman bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.ORCID 0000-0003-2145-5138
Fatmah Hazza AlsharifFaculty of Nursing, King Abdulaziz University, Jeddah 21461, Saudi Arabia.ORCID 0000-0002-4695-346X
Abeer Al TuwaijriMedical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard Health Affairs (MNGH), Riyadh 11481, Saudi Arabia.ORCID 0000-0002-7851-4365

Funding

Princess Nourah bint Abdulrahman University PNURSP2024R150
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerLucidinmolecular dynamics simulationsmultitargeted therapyWaterMap computations

Identifiers

PMID39861131
PMCPMC11768784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.